Drug Therapy

Citations 251-260 of 471 total displayed.

Past content (since Nov 1998):

Reviews
Combination Immunosuppressive Therapies: The Promise and the Peril

Maria R. Robinson; Benjamin D. Korman; Neil J. Korman
Arch Dermatol 2007; 143: 1053-1057. [Abstract] [Full text] [PDF]  

Correspondence
Long-term Follow-up of a Child Treated With Efalizumab for Atopic Dermatitis

Elaine C. Siegfried
Arch Dermatol 2007; 143: 1077-1078. [Extract] [Full text] [PDF]  

Correspondence
Atrial Tachycardia Associated With Isotretinoin Use

Graham Dresden
Arch Dermatol 2007; 143: 1084-1085. [Extract] [Full text] [PDF]  

Editorials
Poor Adherence to Treatments: A Fundamental Principle of Dermatology

Saba M. Ali; Robert T. Brodell; Rajesh Balkrishnan; Steven R. Feldman
Arch Dermatol 2007; 143: 912-915. [Extract] [Full text] [PDF]  

Studies
Pemphigus Variant Associated With Penicillin Use: A Case-Cohort Study of 363 Patients From Israel

Anthony D. Heymann; Gabriel Chodick; Eyal Kramer; Manfred Green; Varda Shalev
Arch Dermatol 2007; 143: 704-707. [Abstract] [Full text] [PDF]  

Studies
Cutaneous Adverse Reactions to Valdecoxib Distinct From Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Mirjana Ziemer; Christiane L. Wiesend; Robert Vetter; Johannes Weiss; Sabine Blaschke; Johannes Norgauer; Maja Mockenhaupt
Arch Dermatol 2007; 143: 711-716. [Abstract] [Full text] [PDF]  

Studies
Long-term Safety and Efficacy of 50 mg of Etanercept Twice Weekly in Patients With Psoriasis

Stephen Tyring; Kenneth B. Gordon; Yves Poulin; Richard G. Langley; Alice B. Gottlieb; Meleana Dunn; Angelika Jahreis
Arch Dermatol 2007; 143: 719-726. [Abstract] [Full text] [PDF]  

Observations
Imatinib as a Treatment Option for Systemic Non-Langerhans Cell Histiocytoses

Jochen Utikal; Selma Ugurel; Hjalmar Kurzen; Philipp Erben; Andreas Reiter; Andreas Hochhaus; Thomas Nebe; Ralf Hildenbrand; Uwe Haberkorn; Sergij Goerdt; Dirk Schadendorf
Arch Dermatol 2007; 143: 736-740. [Abstract] [Full text] [PDF]  

Observations
Erythema Nodosum–like Eruption as a Manifestation of Azathioprine Hypersensitivity in Patients With Inflammatory Bowel Disease

Anne-Laure de Fonclare; Kiarash Khosrotehrani; Sélim Aractingi; Paul Duriez; Jacques Cosnes; Laurent Beaugerie
Arch Dermatol 2007; 143: 744-748. [Abstract] [Full text] [PDF]  

Observations
A Pilot Trial of Rituximab in the Treatment of Patients With Dermatomyositis

Lorinda Chung; Mark C. Genovese; David F. Fiorentino
Arch Dermatol 2007; 143: 763-767. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48